about
A multigene RT-PCR assay used to predict recurrence in early breast cancer: two presentations with contradictory resultsDo serum biomarkers really measure breast cancer?Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancerElevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancerEnhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.Epstein-Barr virus as a marker of biological aggressiveness in breast cancer.Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort.Pharmacogenetics in the treatment of breast cancer.c-myc amplifications in primary breast carcinomas and their local recurrences.The promise of molecular profiling for cancer identification and treatmentCentromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancerA prognostic index for operable, node-negative breast cancer.Predicting aggressive outcome in T1N0M0 breast cancer.High Expression of Urokinase-Type Plasminogen Activator Is Associated with Lymph Node Metastasis of Invasive Ductal Carcinoma of the Breast.Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer.Adjuvant systemic therapy for elderly women with breast cancer.Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort.Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.Prognostic value of miRNA-181a/b in colorectal cancer: a meta-analysis.Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients.Association between the Dietary Inflammatory Index and Risk for Cancer Recurrence and Mortality among Patients with Breast Cancer
P2860
Q24806350-68F25202-58FD-44DF-838C-30BC89B5BC1FQ33454967-4E381AA0-745B-46C0-9C6F-0A622A2322DEQ33831109-06AF67E6-FC7B-4978-9531-8B0322F3C7F1Q34292779-769D0EDB-26B4-466F-9FD4-B06FAC237B99Q34299177-FB9B9D85-AC83-477B-BAD1-C5909E21476BQ34309546-CF4B097F-B487-4550-BED1-AB783EB1FEAFQ34543775-44DFE554-6D81-4F20-B0AB-D80B267046E8Q34631710-663EA055-8612-4CDB-B694-E6CED9AE5E25Q34778940-177C1063-29BC-41CB-B56B-CA873EC6B30EQ35692680-108972EF-B18A-4A68-AA89-D1677E479CBBQ35769894-21959243-E496-4456-92FA-7F1BA4707270Q36148564-5B3CFB44-8612-45BD-9341-01BF8FB0C64EQ36245350-B6B254FA-47AD-4221-B984-654DB34A7FD4Q36694138-86577662-0E93-42AE-BDB1-6891B6F94565Q36695300-83634CAB-50AD-4ACC-BF7B-8A10FA5CBF6BQ37056918-1123E432-6770-43E5-AF5C-529D89A8A3DAQ37350526-3D58718A-D4D2-4923-8D99-94B7C18CBCEAQ37608377-0986F5FA-7822-4E84-8A76-4BAA6B30ABE9Q37689699-EE512405-811F-4338-97F4-5F0EBD4222DEQ46892337-35FB5DE0-ACC7-423F-B1F9-63E2136E2DC4Q53744739-AEDC3295-CBB3-4E27-AFE1-48D49A7D9461Q55036428-2D2C8E43-F328-4110-A420-CAE3B76F8A5BQ58776754-C10EAD55-9116-4B0C-ABEE-1790483D9D9B
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
New prognostic factors for breast cancer recurrence.
@ast
New prognostic factors for breast cancer recurrence.
@en
New prognostic factors for breast cancer recurrence.
@nl
type
label
New prognostic factors for breast cancer recurrence.
@ast
New prognostic factors for breast cancer recurrence.
@en
New prognostic factors for breast cancer recurrence.
@nl
prefLabel
New prognostic factors for breast cancer recurrence.
@ast
New prognostic factors for breast cancer recurrence.
@en
New prognostic factors for breast cancer recurrence.
@nl
P2093
P1433
P1476
New prognostic factors for breast cancer recurrence.
@en
P2093
P356
10.1016/S0093-7754(01)90045-4
P577
2001-02-01T00:00:00Z